[Federal Register Volume 59, Number 66 (Wednesday, April 6, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-8246]
[[Page Unknown]]
[Federal Register: April 6, 1994]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Announcement Number 438]
RIN 0905-ZA28
Cooperative Agreements for Studies To Determine Sources and
Predictors of Lead Poisoning in Young Children; Notice of Availability
of Funds for Fiscal Year 1994
Introduction
The Centers for Disease Control and Prevention (CDC) announces the
availability of fiscal year (FY) 1994 funds for a cooperative agreement
program to conduct studies to determine sources and predictors of lead
poisoning in young children.
The Public Health Service (PHS) is committed to achieving the
health promotion and disease prevention objectives of ``Healthy People
2000,'' a PHS-led national activity to reduce morbidity and mortality
and improve the quality of life. This announcement is related to the
priority area of Environmental Health. (For ordering a copy of
``Healthy People 2000,'' see the section WHERE TO OBTAIN ADDITIONAL
INFORMATION.)
Authority
This program is authorized under sections 301(a) (42 U.S.C. 241(a))
and 317A (42 U.S.C. 247b-1) of the Public Health Service Act, as
amended. Program regulations are set forth in 42 CFR part 51b.
Smoke-Free Workplace
The Public Health Service strongly encourages all cooperative
agreement recipients to provide a smoke-free workplace and promote the
non-use of all tobacco products. This is consistent with the PHS
mission to protect and advance the physical and mental health of the
American people.
Eligible Applicants
Applications may be submitted by public and private, nonprofit and
for-profit organizations and governments and their agencies. Thus,
universities, colleges, research institutions, hospitals, other public
and private organizations, State and local health departments or their
bona fide agents, and small, minority and/or women-owned businesses are
eligible for these cooperative agreements.
Applications will be considered for funding to conduct studies in
one or more programmatic interest areas. Applicants interested in
conducting more than one study must submit a separate application for
each. If a single study addresses more than one programmatic interest
area, only one should be identified as the primary interest area. The
programmatic interest area should be clearly indicated for each study.
Availability of Funds
Approximately $600,000 is available in FY 1994 to fund
approximately three cooperative agreements. It is expected that the
average award will be $200,000 (direct and indirect cost), ranging from
$100,000 to $350,000. It is expected that the awards will begin on or
about September 30, 1994. The awards will be made for 12-month budget
periods within a project period up to 3 years. Funding estimates may
vary and are subject to change based on the availability of funds.
Continuation awards within the project period will be made on the
basis of satisfactory progress and the availability of funds.
Purpose
The purpose of these awards is to study important epidemiologic
questions critical to the implementation, operation, and expansion of
childhood lead poisoning prevention programs, and to support the
development of guidelines and policies. These awards are to study:
1. Sources of lead exposure in children in high-risk communities or
in the general population;
2. Sources of lead exposure in children in day care centers; and
3. The relationship between housing characteristics (that do not
require environmental sampling) and the distribution of blood lead
levels in children.
Program Requirements
To fulfill the objectives of this cooperative agreement, an
applicant must meet the following requirements:
1. A director who has specific authority and responsibility to
carry out the requirements of the project.
2. Demonstrated ability to collect and analyze data needed to
fulfill the study objectives.
3. Demonstrated experience in conducting relevant epidemiologic
studies.
4. Demonstrated effective and well-defined working relationships
within the performing organization and with outside entities which will
ensure implementation of the proposed study.
5. Demonstrated access to a laboratory with demonstrated
proficiency in performing blood lead (and other laboratory measurements
as indicated in the applicant's study protocol).
6. Demonstrated ability to ensure that children identified with
elevated blood levels receive appropriate medical and environmental
management through an ongoing childhood lead poisoning prevention
program (which need not be applicant's organization).
Eligible applicants may enter into contracts, including consortia
agreements, as necessary to meet the requirements of the program and
strengthen the overall application; however, applicants must perform a
substantial portion of the activities for which funds are requested.
Programmatic Interest Areas
The studies must be in one of the following areas:
1. Sources of lead exposure in children in high-risk communities or
in the general population: Determine the relative contribution of
different sources of lead in children. Quantify and model the
contribution of various sources of lead exposure to blood lead levels
among a probability sample of children living in a defined community
(where an industrial point source, such as a smelter, is NOT the
predominant source of lead exposure) in an urban, suburban, or rural
area.
2. Children in day care centers: Assess lead hazards in day care
centers and their contribution to blood lead levels among children
6 years of age, while controlling for household lead
exposure, and other potential determinants of blood lead levels.
3. Lead-based paint hazard predictors of childhood lead poisoning:
Evaluate the relationship between housing characteristics that do not
require environmental sampling (e.g., housing age and condition) and
the geometric mean (and distribution of) blood lead levels in children,
while controlling for other determinants of blood lead levels.
Cooperative Activities
In conducting activities to achieve the purpose of these
cooperative agreements, the recipient will be responsible for
conducting activities under A. (Recipient Activities), and CDC will be
responsible for conducting activities under B. (CDC Activities):
A. Recipient Activities
1. Conduct study activities, including: (1) enrolling eligible
study subjects, after obtaining informed consent; (2) collecting data;
(3) ensuring appropriate medical and environmental management of study
subjects; and (4) conducting all other components required for
implementation of the study.
2. Enter and maintain data into a computerized database.
3. Analyze collected data and prepare a report of the study
findings.
B. CDC Activities
1. Collaborate with recipient in refining approved study protocol
and data collection instrument(s), as appropriate.
2. Provide technical advice on data collection and management.
3. Assist in assessment of quality of laboratory measurements, if
needed.
Evaluation Criteria
Applications will be reviewed and evaluated according to the
following criteria:
1. Study Protocol (30%)
The protocol's scientific soundness, quality, feasibility,
consistency with the project goals, and adequacy of the evaluation
plan.
2. Access to Study Subjects (20%)
Documented ability to identify, access, enroll, and follow study
subjects.
3. Laboratory Capacity (15%)
Documented availability of a laboratory with demonstrated
proficiency in performing lead measurements (and other laboratory
measurements as indicated in applicant's proposed study).
4. Medical and Environmental Management (15%)
Documented ability to ensure that children identified with elevated
blood lead levels receive appropriate medical and environmental
management.
5. Project Personnel (10%)
The qualifications, experience, (including experience in conducting
relevant studies) and time commitment of the staff needed to ensure
implementation of the project.
6. Plan for Administration of Project (10%)
Schedule for implementing, monitoring, and evaluating the project.
7. Budget Justification (Not Scored)
The budget will be evaluated for the extent to which it is
reasonable, clearly justified, and consistent with the intended use of
cooperative agreement funds.
Executive Order 12372 Review
Applications are not subject to the review requirements of
Executive Order 12372 entitled, Intergovernmental Review of Federal
Programs.
Public Health System Reporting Requirement
This program is not subject to the Public Health System Reporting
Requirements.
Catalog of Federal Domestic Assistance Number
The Catalog of Federal Domestic Assistance number assigned to this
program is 93.283.
Other Requirements
Paperwork Reduction Act
Projects that involve the collection of information from ten or
more individuals and funded by this cooperative agreement will be
subject to review by the Office of Management and Budget (OMB) under
the Paperwork Reduction Act.
Human Subjects
If the proposed project involves research on human subjects, the
applicant must comply with the Department of Health and Human Services
Regulations (45 CFR part 46) regarding the protection of human
subjects. Assurance must be provided to demonstrate that the project
will be subject to initial and continuing review by an appropriate
institutional review committee. The applicant will be responsible for
providing assurance in accordance with the appropriate guidelines and
form provided in the application kit.
Application Submission and Deadline
A. Preapplication Letter of Intent
Although not a prerequisite of application, a non-binding letter of
intent-to-apply is requested from potential applicants. The letter
should be submitted to the Grants Management Officer (whose address is
reflected in section B, ``Applications''). It should be postmarked no
later than one month prior to the planned submission deadline, (e.g.,
May 17 for June 17 submission).
The letter should identify the announcement number, indicate the
intended submission deadline, name the principal investigator, and
specify the study area addressed by the proposed project.
The letter of intent does not influence review of funding
decisions, but it will enable CDC to plan the review more efficiently,
and will ensure that each applicant receives timely and relevant
information prior to application submission.
B. Applications
All applicants should use Form PHS-398 and adhere to the ERRATA
Instruction Sheet for form PHS-398. The original and five copies must
be submitted to Henry S. Cassell, III, Grants Management Officer,
Grants Management Branch, Procurement and Grants Office, Centers for
Disease Control and Prevention (CDC), 255 East Paces Ferry Road, NE.,
room 321, Atlanta, GA 30305, on or before June 17, 1994.
C. Deadline
1. Applications shall be considered as meeting the deadline if they
are either:
A. Received on or before the deadline date, or
B. Sent on or before the deadline date and received in time for
submission for the review process. Applicants must request a legibly
dated U.S. Postal Service Postmark or obtain a legibly dated receipt
from a commercial carrier or U.S. Postal Service. Private metered
postmarks shall not be acceptable as proof of timely mailing.
2. Late Applications: Applications which do not meet the criteria
in 1.A. or 1.B. above are considered late applications. Late
applications will not be considered in the current competition and will
be returned to the applicant.
Where to Obtain Additional Information
To receive additional written information call (404) 332-4561. You
will be asked to leave your name, address and phone number and will
need to refer to Announcement 438. You will receive a complete program
description, information on application procedures, and application
forms.
If you have questions after reviewing the contents of all
documents, business management technical assistance may be obtained
from Lisa Tamaroff, Grants Management Specialist, Grants Management
Branch, Procurement and Grants Office, Centers for Disease Control and
Prevention (CDC), 255 East Paces Ferry Road, NE., room 321, Mailstop E-
13, Atlanta, GA 30305, telephone (404) 842-6796.
Please refer to Announcement Number 438 when requesting information
and submitting an application.
Programmatic technical assistance may be obtained from Lisa
Rosenblum, M.D., Lead Poisoning Prevention Branch, Division of
Environmental Hazards and Health Effects, National Center for
Environmental Health, Centers for Disease Control and Prevention (CDC),
4770 Buford Highway, NE., Mailstop F-42, Atlanta, GA 30341-3724,
telephone (404) 488-7330.
Potential applicants may obtain a copy of ``Healthy People 2000''
(Full Report, Stock No. 017-001-00474-0) or ``Healthy People 2000''
(Summary Report, Stock No. 017-001-00473-1) through the Superintendent
of Documents, Government Printing Office, Washington, DC 20402-9325,
telephone (202) 783-3238.
To receive a copy of the Strategic Plan for the Elimination of
Childhood Lead Poisoning, contact the Lead Poisoning Prevention Branch,
Division of Environmental Hazards and Health Effects, National Center
for Environmental Health, Centers for Disease Control and Prevention
(CDC), 4770 Buford Highway, NE., Mailstop F-42, Atlanta, GA 30341-3724,
telephone (404) 488-7330.
Dated: March 31, 1994.
Robert L. Foster,
Acting Associate Director for Management and Operations, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 94-8246 Filed 4-5-94; 8:45 am]
BILLING CODE 4163-18-P
